This NDC is on FDA's drug shortage list (posted Sep 5, 2018)

Reported reason: Demand increase for the drug

Product Information

LORAZEPAM 2 MG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.1227 per ML under NDC 00641604425. Its NADAC has been published 360 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.

LORAZEPAM 2 MG/ML VIAL

Lorazepam
$2.1227per ML
DEA Schedule CIV

Strength

2 mg/mL

NDC

00641604425

Classification

Generic

Dosage Form

INJECTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

10/21/2026

Active Ingredients

LORAZEPAM

Approval Type

New Drug (NDA)

FDA Application

NDA018140

FDA Approved

Before 1982

TE Code

AP

On Market Since

7/25/1980

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for LORAZEPAM 2 MG/ML VIAL has been published 360 times since Nov 28, 2013, and over the history we have for it it has risen 186.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2.1227 per ML
All-time high$2.1715 (Oct 14, 2026)
All-time low$0.5839 (Nov 19, 2014)
52-week high$2.1715
52-week low$1.0891
Median price$0.7135
Average price$0.8763
Largest weekly change+65.7% (Dec 18, 2024)
Weeks tracked360
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-2.2%

3M

+3.9%

6M

+16.5%

1Y

+94.9%

3Y

+222.9%

5Y

+222.9%

All

+186.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 68% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LORAZEPAM 2 MG/ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $2.1227 per ML (NDC 00641604425), effective Nov 11, 2026.

How has the price of LORAZEPAM 2 MG/ML VIAL changed over time?

Over the history we have for it, the NADAC for LORAZEPAM 2 MG/ML VIAL has risen 186.9%. It has been tracked across 360 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG/ML VIAL?

Since Nov 28, 2013, the NADAC for LORAZEPAM 2 MG/ML VIAL has ranged from a low of $0.5839 (Nov 19, 2014) to a high of $2.1715 (Oct 14, 2026), with a median of $0.7135 per ML.

Are there cheaper alternatives to LORAZEPAM 2 MG/ML VIAL?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 20 MG/10 ML VIAL, is $0.6796 per ML — about 68% below LORAZEPAM 2 MG/ML VIAL.

Who manufactures LORAZEPAM 2 MG/ML VIAL?

LORAZEPAM 2 MG/ML VIAL (NDC 00641604425) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.

Is LORAZEPAM 2 MG/ML VIAL in shortage?

Yes — NDC 00641604425 is currently listed in FDA's drug shortage database (posted Sep 5, 2018). Reported reason: Demand increase for the drug.